← Back to patent-cliff list
CAS 184766-32-3
(E)-5-(4-(2-(5-(1-(methoxymethoxy)ethyl)pyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione
Codes: HYPIL-009
Application context (from source-drug indications)
肾上腺脑白质营养不良LeriglitazoneFriedreich's ataxiaLeriglitazone
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Leriglitazone | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
5-(4-(2-(5-(1-(methoxymethoxy)ethyl)pyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione→Hydroxypioglitazone→methyl 6-methylnicotinate→1-(6-methylpyridin-3-yl)ethanone→1-(6-methylpyridin-3-yl)ethanol→5-(1-(methoxymethoxy)ethyl)-2-methylpyridine→2-(5-(1-(methoxymethoxy)ethyl)pyridin-2-yl)ethanol→4-hydroxybenzaldehyde→4-(2-(5-(1-(methoxymethoxy)ethyl)pyridin-2-yl)ethoxy)benzaldehyde→thiazolidine-2,4-dione→(E)-5-(4-(2-(5-(1-(methoxymethoxy)ethyl)pyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.